Cecilia Jones

Insider Reports History

Entity
Individual
Location
C/O Logicbio Therapeutics, Inc., 65 Hayden Avenue, 2 Nd Floor, Lexington, Massachusetts
Signature
/s/ William Cook, as attorney-in-fact for Cecilia Jones
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cecilia Jones:

Stock Role Class Num Shares Value Price $ Report Date Ownership
AGIOS PHARMACEUTICALS, INC. Chief Financial Officer Common stock 14.8K $483K $32.57 Mar 5, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Chief Financial Officer Restricted stock units 4K $130K $32.57 Mar 1, 2024 Direct
LogicBio Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 112K Mar 1, 2022 Direct
AGIOS PHARMACEUTICALS, INC. Chief Financial Officer Stock options (right to buy) 60K Mar 1, 2024 Direct
AGIOS PHARMACEUTICALS, INC. Chief Financial Officer Performance share units 0 $21.64 Jan 20, 2024 Direct

Insider Reports Filed by Cecilia Jones

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AGIO AGIOS PHARMACEUTICALS, INC. Mar 1, 2024 5 -$21.9K 4 Mar 5, 2024 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Jan 20, 2024 3 -$40.8K 4 Jan 24, 2024 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Sep 26, 2023 3 -$54K 4 Sep 28, 2023 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Jun 28, 2023 3 -$45.3K 4 Jun 30, 2023 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Mar 1, 2023 2 $0 4 Mar 3, 2023 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Sep 26, 2022 2 $0 4 Sep 28, 2022 Chief Financial Officer
AGIO AGIOS PHARMACEUTICALS, INC. Sep 26, 2022 0 $0 3 Sep 28, 2022 Chief Financial Officer
LOGC LogicBio Therapeutics, Inc. Mar 1, 2022 1 $0 4 Mar 3, 2022 Chief Financial Officer
LOGC LogicBio Therapeutics, Inc. Jan 11, 2022 3 -$4.37K 4 Jan 13, 2022 Chief Financial Officer